Pseudoephedrine Behind-The-Counter Sale Proposed In Congress; CHPA Balks

The efficacy of an Oklahoma law moving pseudoephedrine-containing products behind the counter must be evaluated over an extended follow-up period before extending legislation nationwide, according to industry trade group and DEA topsiders